Bosutinib (SKI-606)
Bosutinib (SKI-606) is a tyrosine kinase inhibitor undergoing research for use in the treatment of cancer.
Free Delivery on orders over $500
Important Notice: For research use only. We do not sell to patients.
Important Notice: For research use only. We do not sell to patients.
Discription | Bosutinib (SKI-606) is a tyrosine kinase inhibitor undergoing research for use in the treatment of cancer. | ||
---|---|---|---|
Targets |
|
Catalog Num | A10161 |
---|---|
Formula | C26H29Cl2N5O3 |
Molecular Weight | 530.4 |
CAS Number | 380843-75-4 |
SMILES | CN1CCN(CC1)CCCOC2=C(C=C3C(=C2)N=CC(=C3NC4=CC(=C(C=C4Cl)Cl)OC)C#N)OC |
Storage | Store lyophilized at -20ºC, keep desiccated. |
In vitro (25°C) | DMSO | 93 mg/mL (175.31 mM) | |
Water | Insoluble | ||
Ethanol | 2 mg/mL (3.77 mM) | ||
In vivo | 2% DMSO+30% PEG 300+5% Tween 80+ddH2O | 9 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 18.85 mL | 94.27 mL | 188.54 mL |
0.5 mM | 3.77 mL | 18.85 mL | 37.71 mL |
1 mM | 1.89 mL | 9.43 mL | 18.85 mL |
5 mM | 0.38 mL | 1.89 mL | 3.77 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2